Tacrolimus (FK 506)—A New Therapeutic Agent for Severe Recalcitrant Psoriasis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Severe Psoriasis – Oral Therapy with a New Retinoid
1978 • 2,660 citations
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
1991 • 1,479 citations
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.
1987 • 1,209 citations
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
1989 • 1,043 citations
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.
1989 • 667 citations
Cyclosporine Improves Psoriasis in a Double-blind Study
1986 • 535 citations
Liver, Kidney, and Thoracic Organ Transplantation Under FK 506
1990 • 252 citations
Role of Growth Factors, Cytokines, and Their Receptors in the Pathogenesis of Psoriasis
1990 • 248 citations
A highly sensitive method to assay FK-506 levels in plasma.
1987 • 149 citations
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
1990 • 108 citations
Psoriatic Epidermal Cells Demonstrate Increased Numbers and Function of Non-Langerhans Antigen-presenting Cells
1989 • 105 citations
HEPATOTROPHIC EFFECTS OF FK506 IN DOGS
1991 • 83 citations
Four years of experience with cyclosporin A for psoriasis
1990 • 46 citations
Conversion of liver allograft recipients with cyclosporine related complications from cyclosporine to FK 506
1990 • 32 citations
Convulsions with an occult neural-crest tumor.
1979 • 15 citations
Cited By (0)
No citing papers found in database